Adaptive Biotechnologies - ADPT Company Short-Term Debt

Graphic logo of Adaptive Biotechnologies (ADPT)

Adaptive Biotechnologies is developing a closed genomic analysis environment where expansion rates depend on FDA verdicts. Reliable express logistics for biomaterials minimize losses, maintaining profitability. Visionary management is successfully commercializing scientific discoveries. The short-term borrowing trajectory on the GURU.Markets chart demonstrates debt dynamics, with 0.03 serving as the final level mark.

ADPT (Adaptive Biotech) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Adaptive Biotechnologies Inc. - analytical breakdowns and key metrics (ADPT)

- price and consensus price forecast:
Price Chart Adaptive Biotechnologies Corporation|ADPT - Fair Value Consensus
- market capitalization data:
Market Value Adaptive Biotechnologies Corporation|ADPT - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Adaptive Biotechnologies|ADPT - Book Capitalization|Market Cap to Net Assets Ratio adaptivebiotech.com|ADPT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Adaptive Biotechnologies|ADPT - Company Total Debt|Debt to Book Capitalization Ratio Adaptive Biotechnologies Corporation|ADPT - Company Long-Term Liabilities|Company Current Liabilities Adaptive Biotechnologies
Fundamental company valuation:Adaptive Biotechnologies Corporation - ADPT
Product sample of Adaptive Biotechnologies

Adaptive Biotechnologies generates stable income from its immunosequencing patent portfolio, which necessitates strict liquidity control to maintain operational momentum. An analysis of short-term debt financing allows for an assessment of obligations maturing within one year, identifying refinancing risks and providing investors with a real-time valuation of the issuer's financial stability to protect capital.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts CLDX|Aurinia Corp - Short-Term Debt Volume|BCRX: Company Short-Term Debt|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics, Inc.) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|ABCL (AbCellera Biologics) - Company Current Liabilities|Company Short-Term Debts TRML|Company Short-Term Debt Precigen, Inc. PGEN|Company Short-Term Indebtedness pharming.com (PHAR)|NKTR: Company Short-Term Debts|Short-Term Debt Upstream Bio, Inc. UPB|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM - Company Short-Term Debts|Company Short-Term Debts Gossamer Bio, Inc.|kalvista.com (KALV) - Company Short-Term Indebtedness|SEPN (Septerna) - Company Short-Term Debts|Company Short-Term Debts PVLA|SVRA - Company Short-Term Debt|Current Liabilities Rigel Corp RIGL|Company Current Liabilities AnaptysBio, Inc. (ANAB)|Amount of Current Liabilities astriatx.com ATXS|Company Short-Term Debts ENGN (enGene)|rapt.com (RAPT) - Short-Term Debt Volume|aerovatetx.com (JBIO) - Company Current Liabilities|Aclaris Therapeutics, Inc (ACRS) - Company Short-Term Debt|Company Short-Term Debts KYTX (Kyverna Therapeutics)|Short-Term Debt tizianalifesciences.com (TLSA)|Cabaletta Bio (CABA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Ventyx Biosciences Inc. (VTYX)|Company Short-Term Debts Theratechnologies Inc THTX|Company Short-Term Debt Avalo Therapeutics Inc AVTX|Company Short-Term Debts ELDN (Eledon Pharmaceuticals)|AGEN: Short-Term Debt Volume|Company Short-Term Debt CLYM|Short-Term Debt zurabio.com|aTyr (ATYR) - Company Current Liabilities|Amount of Current Liabilities Adagene Corp|ImageneBio Inc - Company Short-Term Debts|Short-Term Debt shattucklabs.com (STTK)|Equillium - Company Short-Term Debts|Company Current Liabilities Connect Biopharma Holdings CNTB|Company Short-Term Debts Immunic Inc (IMUX)|ATRA: Company Short-Term Loans and Borrowings|Company Short-Term Debt inflarx.de|XFOR (x4pharma.com) - Company Short-Term Indebtedness|Company Short-Term Debt ACET (Adicet Bio Inc.)|Short-Term Debt CELU|Company Short-Term Debt INmune Bio Corp (INMB)|Company Short-Term Debt BRNS (Barinthus Biotherapeutics Corp)|KZR: Company Short-Term Debt|Short-Term Debt sabbiotherapeutics.com SABS|Company Short-Term Debts AKTX|ENLV - Short-Term Indebtedness|q32bio.com - Company Short-Term Debts|GeoVax Corp (GOVX) - Short-Term Debt Volume|Company Short-Term Debts EDSA (Edesa Biotech, Inc.)|Short-Term Debt IBIO|CARM (Carisma Therapeutics) - Company Short-Term Debt|Short-Term Debt Volume XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|Aptevo (APVO) - Company Short-Term Debts|AIM: Company Short-Term Indebtedness|Company Short-Term Debt aditxt.com (ADTX)|Current Liabilities GRI Bio Inc|XORTX (XRTX) - Company Current Liabilities|Amount of Current Liabilities HIND|REVB - Company Short-Term Debt|Current Liabilities indaptusrx.com (INDP)|Company Short-Term Debts Scinai Immunotherapeutics Ltd.|Company Short-Term Loans and Borrowings CalciMedica Inc CALI|Affimed Therapeutics - Company Short-Term Debts|ALLK: Company Short-Term Debts|Company Short-Term Debt hookipapharma.com HOOK|IGMS (IGM Biosciences) - Company Short-Term Loans and Borrowings|Company Short-Term Debt ITOS|Company Current Liabilities Ocean Biomedical Inc|Company Short-Term Debts TCBP|Company Short-Term Debts Third Harmonic Bio Inc THRD